Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia

Conditions

• Glucosephosphate Dehydrogenase Deficiency
• Hyperbilirubinemia
• Hemolytic Disease of Newborn

Interventions

• DRUG: tin mesoporphyrin

Sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborators

• [object Object]